Molecular Determinants of Response to Neoadjuvant Pembrolizumab Plus Chemotherapy in Patients with High-Risk, Early-Stage, Triple-Negative Breast Cancer: Exploratory Analysis of the Open-Label, Multicohort Phase 1b KEYNOTE-173 Study
Breast Cancer Research(2025)
关键词
Immunohistochemistry,Triple-negative breast cancer,Tumor microenvironment
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要